glucose, (beta-d)-isomer has been researched along with Respiratory Insufficiency in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carson, JR; Codd, EE; Colburn, RW; Dax, SL; Flores, CM; Gallantine, EL; Meert, TF; Molino, L; Pullan, S; Razler, CM; Stone, DJ; Van Besien, CR; Wade, PR; Zhang, SP | 1 |
| Bai, X; Dong, H; Du, K; Han, H; Hou, L; Hu, S; Huang, Y; Li, S; Lu, Y; Mu, J; Pei, Y; Wang, W; Xiong, L; Zhang, Z; Zhao, Y | 1 |
| Cone, JB; Ferrer, TJ; Hauer-Jensen, M; Wallace, BH; Wang, J | 1 |
| Dunham, B; Hechtman, HB; Krausz, MM; Shepro, D; Utsunomiya, T; Valeri, CR | 1 |
| Chamberlin, W; Chen, H; Hegarty, M; Nahum, A; Sznajder, JI | 1 |
| Abdulrahman, N; Eldassouki, H; Gadeau, AP; Imran, Z; Ismail, R; Moustafa, DA; Mraiche, F; Rayan, M | 1 |
| Ambery, P; Berwanger, O; Buenconsejo, J; Chopra, V; Esterline, R; Gasparyan, SB; Javaheri, A; Koch, GG; Kosiborod, M; Langkilde, AM; Martinez, F; Mukhtar, O; Oscarsson, J; Sjöström, CD; Verma, S | 1 |
| Blitzer, MG; Dunn, DW; Shapira, E; Temple, JK | 1 |
1 review(s) available for glucose, (beta-d)-isomer and Respiratory Insufficiency
| Article | Year |
|---|---|
Evaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin-angiotensin-aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID
Topics: Angiotensin-Converting Enzyme 2; Benzhydryl Compounds; Clinical Trials, Phase III as Topic; COVID-19; Double-Blind Method; Drug Repositioning; Glucosides; Heart Diseases; Humans; Kidney Diseases; Mitochondria; Multicenter Studies as Topic; Oxidative Stress; Randomized Controlled Trials as Topic; Receptors, Virus; Renin-Angiotensin System; Respiratory Insufficiency; SARS-CoV-2; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
2 trial(s) available for glucose, (beta-d)-isomer and Respiratory Insufficiency
| Article | Year |
|---|---|
Alterations in endothelial thrombomodulin expression in zymosan-induced lung injury.
Topics: Animals; Down-Regulation; Endothelium, Vascular; Immunoenzyme Techniques; Lung; Male; Rats; Rats, Sprague-Dawley; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Thrombomodulin; Zymosan | 2003 |
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study.
Topics: Atherosclerosis; Benzhydryl Compounds; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cause of Death; Comorbidity; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Glucosides; Heart Failure; Humans; Hypertension; Kidney Diseases; Mortality; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Respiratory Insufficiency; SARS-CoV-2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2021 |
5 other study(ies) available for glucose, (beta-d)-isomer and Respiratory Insufficiency
| Article | Year |
|---|---|
JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic toler
Topics: Alfentanil; Analgesics, Opioid; Animals; Azabicyclo Compounds; Cricetinae; Drug Tolerance; Gastrointestinal Motility; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Hyperalgesia; Irritants; Male; Mice; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid, delta; Respiratory Insufficiency; Seizures; Self Administration; Stomach Ulcer; Substance Withdrawal Syndrome; Substance-Related Disorders; Xanthenes; Zymosan | 2009 |
Activation of cholinergic anti-inflammatory pathway contributes to the protective effects of 100% oxygen inhalation on zymosan-induced generalized inflammation in mice.
Topics: Aconitine; Animals; Cytokines; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Lung; Male; Mecamylamine; Mice; Mice, Inbred ICR; Myocardium; Nicotinic Antagonists; Oxygen; Receptors, Nicotinic; Respiratory Insufficiency; Systemic Inflammatory Response Syndrome; Vagotomy; Zymosan | 2012 |
Inhibition of permeability edema with imidazole.
Topics: Animals; Blood Platelets; Complement Activation; Epoprostenol; Imidazoles; Leukocyte Count; Lung; Lymph; Platelet Aggregation; Pulmonary Edema; Respiratory Insufficiency; Thromboxane A2; Zymosan | 1982 |
Effect of sodium azide on hydrogen peroxide production by zymosan-activated human neutrophils.
Topics: Adult; Azides; Fluorometry; Humans; Hydrogen Peroxide; Hypoxia; Middle Aged; Neutrophils; Oxidation-Reduction; Peroxidase; Phenylacetates; Respiratory Insufficiency; Sodium Azide; Zymosan | 1990 |
The "muscular variant" of Pompe disease: clinical, biochemical and histologic characteristics.
Topics: alpha-Glucosidases; Child, Preschool; Fibroblasts; Genes, Recessive; Genetic Variation; Glucosides; Glycogen Storage Disease; Glycogen Storage Disease Type II; Humans; Hymecromone; Leukocytes; Male; Muscles; Muscular Diseases; Respiratory Insufficiency | 1985 |